BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28526008)

  • 1. Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.
    Magnussen SN; Hadler-Olsen E; Costea DE; Berg E; Jacobsen CC; Mortensen B; Salo T; Martinez-Zubiaurre I; Winberg JO; Uhlin-Hansen L; Svineng G
    BMC Cancer; 2017 May; 17(1):350. PubMed ID: 28526008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation.
    Bernstein AM; Twining SS; Warejcka DJ; Tall E; Masur SK
    Mol Biol Cell; 2007 Jul; 18(7):2716-27. PubMed ID: 17507651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of uPAR retards radiation-induced invasion and migration mediated by integrin β1/FAK signaling in medulloblastoma.
    Nalla AK; Asuthkar S; Bhoopathi P; Gujrati M; Dinh DH; Rao JS
    PLoS One; 2010 Sep; 5(9):e13006. PubMed ID: 20886051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma.
    Wang S; Jiang L; Han Y; Chew SH; Ohara Y; Akatsuka S; Weng L; Kawaguchi K; Fukui T; Sekido Y; Yokoi K; Toyokuni S
    Oncotarget; 2016 Oct; 7(43):69565-69578. PubMed ID: 27602956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase-Type Plasminogen Activator Receptor (uPAR) Expression and [
    Lawaetz M; Binderup T; Christensen A; Juhl K; Lelkaitis G; Lykke E; Knudsen L; von Buchwald C; Kjaer A
    Mol Imaging Biol; 2023 Dec; 25(6):1034-1044. PubMed ID: 37749438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-β signals promote progression of squamous cell carcinoma by inducing epithelial-mesenchymal transition and angiogenesis.
    Ibi H; Takahashi K; Harada H; Watabe T; Podyma-Inoue KA
    Biochem Biophys Res Commun; 2024 Jun; 714():149965. PubMed ID: 38657447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIEN1 promotes oral cancer progression and implicates poor overall survival.
    Rajendiran S; Kpetemey M; Maji S; Gibbs LD; Dasgupta S; Mantsch R; Hare RJ; Vishwanatha JK
    Cancer Biol Ther; 2015; 16(6):876-85. PubMed ID: 25996585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.
    Mahmood N; Mihalcioiu C; Rabbani SA
    Front Oncol; 2018; 8():24. PubMed ID: 29484286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transcriptional regulation of urokinase-type plasminogen activator receptor expression in lipopolysaccharide-induced acute lung injury.
    Bhandary YP; Velusamy T; Shetty P; Shetty RS; Idell S; Cines DB; Jain D; Bdeir K; Abraham E; Tsuruta Y; Shetty S
    Am J Respir Crit Care Med; 2009 Feb; 179(4):288-98. PubMed ID: 19029002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic evaluation of oral squamous cell carcinoma based on pleiotrophin, urokinase plasminogen activator, and glycoprotein nonmetastatic melanoma protein B expression.
    Ma Y; Liu Y; Meng H
    Medicine (Baltimore); 2023 Nov; 102(45):e35634. PubMed ID: 37960806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution.
    Alexander RA; Prager GW; Mihaly-Bison J; Uhrin P; Sunzenauer S; Binder BR; Schütz GJ; Freissmuth M; Breuss JM
    Cardiovasc Res; 2012 Apr; 94(1):125-35. PubMed ID: 22287577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets.
    Kumar AA; Buckley BJ; Ranson M
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The urokinase plasminogen activator receptor promotes efferocytosis of apoptotic cells.
    D'mello V; Singh S; Wu Y; Birge RB
    J Biol Chem; 2009 Jun; 284(25):17030-17038. PubMed ID: 19383607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase-Type Plasminogen Activator Receptor Regulates Prosurvival and Angiogenic Properties of Cardiac Mesenchymal Stromal Cells.
    Dergilev K; Tsokolaeva Z; Goltseva Y; Beloglazova I; Ratner E; Parfyonova Y
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dual role for ERK-1/2 in the regulation of plasmin activity and cell migration in metastatic NSCLC-H1299 cells.
    Zeitlmayr S; Cami D; Selmani B; Gudermann T; Breit A
    Arch Toxicol; 2023 Dec; 97(12):3113-3128. PubMed ID: 37712947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role for the Aryl Hydrocarbon Receptor and Diverse Ligands in Oral Squamous Cell Carcinoma Migration and Tumorigenesis.
    Stanford EA; Ramirez-Cardenas A; Wang Z; Novikov O; Alamoud K; Koutrakis P; Mizgerd JP; Genco CA; Kukuruzinska M; Monti S; Bais MV; Sherr DH
    Mol Cancer Res; 2016 Aug; 14(8):696-706. PubMed ID: 27130942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II - AT1 receptor signalling regulates the plasminogen-plasmin system in human stromal endometrial cells increasing extracellular matrix degradation, cell migration and inducing a proinflammatory profile.
    Zanon P; Terraciano PB; Quandt L; Palma Kuhl C; Pandolfi Passos E; Berger M
    Biochem Pharmacol; 2024 May; ():116280. PubMed ID: 38735446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carotenoids in Cancer Metastasis-Status Quo and Outlook.
    Koklesova L; Liskova A; Samec M; Zhai K; Abotaleb M; Ashrafizadeh M; Brockmueller A; Shakibaei M; Biringer K; Bugos O; Najafi M; Golubnitschaja O; Büsselberg D; Kubatka P
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33321708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing the invasive traits of breast cancers by CYP1B1 via regulation of p53 to promote uPAR expression.
    Kwon YJ; Kwon TU; Shin S; Lee B; Lee H; Park H; Kim D; Moon A; Chun YJ
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166868. PubMed ID: 37661069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDCA5 promoted cell invasion and migration by activating TGF-β1 pathway in human ovarian cancer cells.
    Zhang Q; Zhang R; Li Y; Yang X
    J Ovarian Res; 2024 Mar; 17(1):68. PubMed ID: 38539247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.